XB-IMG-171564
Xenbase Image ID: 171564
|
Figure 4 CS treatment does not alter neuroepithelial organization.
Embryos were exposed to either control or CS
solutions (10 mg/mL) at stage 33/34 and examined at stage
40. (A)–(B) Confocal images of control (A) and CS (B)-
treated brain sections stained with anti-BrdU following
BrdU injections at stage 40. BrdU incorporation was restricted
to the ventricular surface (vs) of the neuroepithelium
and was unaffected by CS treatment. Exposed side is
to the left. (C)–(D) Major axon tracts were not affected by
CS treatment as seen with antiacetylated tubulin staining in
wholemount control (C) and CS-treated (D) brains. Dorsal
is up, anterior to the left. Scale bar is 100 m in (C) and (D)
and 50 m in (A) and (B). Image published in: Walz A et al. (2002) Copyright © 2002. Image reproduced with permission of the Publisher. Larger Image Printer Friendly View |